Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Transforming obesity: The advancement of multi-receptor drugs
2024 Standout
Diagnosis and management of ANCA-associated vasculitis
2024 Standout
3 intermediate papers

Works of Trageen Baumgart being referenced

Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study
2016
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Trageen Baumgart 353 84 105 229 154 9 622
Robert Yelenosky 210 36 103 82 79 12 667
Glenn R. Ehresmann 251 77 102 67 45 13 726
Charles J. Pruchno 200 23 55 84 248 12 523
Raïfah Makdassi 233 67 106 66 381 10 658
Anna J. Strachan 324 54 59 51 59 8 585
Kristy L. Edgtton 321 15 30 114 151 11 684
Takero Naito 220 76 28 50 288 16 626
Bao Lu 379 58 35 48 134 9 577
Yukimasa Hisada 234 122 41 57 219 18 591
Jan-Hendrik Riedel 495 84 16 74 149 13 651

All Works

Loading papers...

Rankless by CCL
2026